This site is intended for U.S. Healthcare Professionals only.

MENU

Purified from human plasma by Cohn cold ethanol fractionation process, ALBUKED contains:   

ALBUKED 5 [Albumin (Human), USP]1

  • 5% sterile albumin in aqueous diluent
  • Stabilized with:

• 0.004 M sodium caprylate

• 0.004 M acetyltryptophan

  • Aluminum content ≤ 200 mg/L
  • Approximate sodium content 145 mEq/L
  • Contains no preservative

ALBUKED 25 [Albumin (Human), USP]2

  • 25% sterile albumin in aqueous diluent
  • Stabilized with:

• 0.02 M sodium caprylate

• 0.02 M acetyltryptophan

  • Aluminum content ≤ 200 mg/L
  • Approximate sodium content 145 mEq/L
  • Contains no preservative

References: 1. AlbukedTM 5 [prescribing information]. Fort Lee, NJ. Kedrion Biopharma Inc. 2014; 2. AlbukedTM 25 [prescribing information]. Fort Lee, NJ. Kedrion Biopharma Inc. 2014.


INDICATIONS AND USAGE

ALBUKED (Albumin [Human], USP) is available in two concentrations, 5% (ALBUKED 5) and 25% (ALBUKED 25), for the following indications: emergency treatment of hypovolemic shock, burn therapy, hypoproteinemia with or without edema, adult respiratory distress syndrome (ARDS), cardiopulmonary bypass, acute liver failure, sequestration of protein rich fluids. See Indications for additional information.

Situations in Which ALBUKED is NOT Warranted: In chronic nephrosis, infused albumin is promptly excreted by the kidneys with no relief of the chronic edema or effect on the underlying renal lesion. It is of occasional use in the rapid “priming” diuresis of nephrosis. Similarly, in hypoproteinemic states associated with chronic cirrhosis, malabsorption, protein losing enteropathies, pancreatic insufficiency, and undernutrition, the infusion of albumin as a source of protein nutrition is not justified. 

IMPORTANT SAFETY INFORMATION